FDA Brief

Company record

GE Healthcare Ireland Limited

0 FDA warning letters since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about GE Healthcare Ireland Limited.

Recalls

ReportedClassFirmProduct and reason
Apr 15 Class II GE Healthcare Ireland Limited
Drug
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.
Presence of particulate matter
FDA notice D-0448-2026
Apr 15 Class II GE Healthcare Ireland Limited
Drug
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.
Presence of particulate matter
FDA notice D-0447-2026